feed,title,long_url,short_url
Benzinga,BioMarin Shares 5-Year Data From Open-Label Trial Of Hemophilia Gene Therapy,https://benzinga.com/general/biotech/21/07/22086372/biomarin-shares-5-year-data-from-open-label-trial-of-hemophilia-gene-therapy,https://j.mp/3hWNS29
